Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Mareks disease virus

Virology Journal

Volumn 9, Issue , 2012, Pages

  Matsuyama Kato, Ayumi ^a   Murata, Shiro ^a   Isezaki, Masayoshi ^a   Kano, Rika ^a   Takasaki, Sara ^a   Ichii, Osamu ^a   Konnai, Satoru ^a   Ohashi, Kazuhiko ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL IMMORTALIZATION; CHICKEN; FIBROBLAST CULTURE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MAREK DISEASE; MOLECULAR DYNAMICS; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD274; CELL LINE; CHICKENS; COCULTURE TECHNIQUES; FIBROBLASTS; GENE EXPRESSION PROFILING; IMMUNE EVASION; IMMUNE TOLERANCE; INTERFERON-GAMMA; MARDIVIRUS; MAREK DISEASE; PROGRAMMED CELL DEATH 1 RECEPTOR; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

GALLUS GALLUS;

EID: 84861206901     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-94     Document Type: Article

References (43)

1. Mareks disease. Schat KA, Nair V, Disease of poultry Blackwell Publishing, Iowa, Saif YM, 12 2008 452 514
2. Characterization of Mareks disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells. Shek W, Calnek B, Schat K, Chen C, J Natl Cancer Inst 1983 70 485 491 6300499 (Pubitemid 13117196)
3. Mareks disease virus down-regulates surface expression of MHC (B Complex) Class I (BF) glycoproteins during active but not latent infection of chicken cells. Hunt H, Lupiani B, Miller M, Gimeno I, Lee LF, Parcells MS, Virology 2001 282 198 205 10.1006/viro.2000.0797 11259202 (Pubitemid 32881787)
4. Apoptosis and CD8-down-regulation in the thymus of chickens infected with Mareks disease virus. Morimura T, Ohashi K, Kon Y, Hattori M, Sugimoto C, Onuma M, Arch Virol 1996 141 2243 2249 10.1007/BF01718230 8973538 (Pubitemid 27012285)
5. Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Jones D, Lee L, Liu JL, Kung HJ, Tillotson JK, Proc Natl Acad Sci USA 1992 89 4042 4046 10.1073/pnas.89.9.4042 1315048
6. Mareks disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses. Levy AM, Gilad O, Xia L, Izumiya Y, Choi J, Tsalenko A, Yakhini Z, Witter R, Lee L, Cardona C, Kung HJ, Proc Natl Acad Sci USA 2005 102 14831 14836 10.1073/pnas.0506849102 16203997 (Pubitemid 41457141)
7. Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis. Liu JL, Ye Y, Lee LF, Kung HJ, J Virol 1998 72 388 395 9420237 (Pubitemid 28048850)
8. Mareks disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Lupiani B, Lee LF, Cui X, Gimeno I, Anderson A, Morgan R, Silva R, Witter R, Kung H-J, Reddy SM, Proc Natl Acad Sci USA 2004 101 11815 11820 10.1073/pnas.0404508101 15289599 (Pubitemid 39095377)
9. Increased virulence of Mareks disease virus field isolates. Witter RL, Avian Dis 1997 41 149 163 10.2307/1592455 9087332 (Pubitemid 27153252)
10. The role of histocompatibility antigens in cell-mediated cytotoxicity against Mareks disease tumour-derived lymphoblastoid cell lines. Powell PC, Mustill BM, Rennie M, Avian Pathol 1983 12 461 468 10.1080/03079458308436191 18766805
11. Cytokine gene expression patterns associated with immunization against Mareks disease in chickens. Abdul-Careem MF, Hunter BD, Parvizi P, Haghighi HR, Thanthrige-Don N, Sharif S, Vaccine 2007 25 424 432 10.1016/j.vaccine.2006.08. 006 17070626 (Pubitemid 44856099)
12. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, Walker B, Sullivan J, Phillips R, Pape GR, Klenerman P, J Virol 2001 75 5550 5558 10.1128/JVI.75.12.5550-5558.2001 11356962 (Pubitemid 32488148)
13. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS, Routy JP, Haddad EK, Sekaly RP, Nat Med 2006 12 1198 1202 10.1038/nm1482 16917489 (Pubitemid 44527357)
14. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T, J Exp Med 2000 192 1027 1034 10.1084/jem.192.7.1027 11015443
15. PD-1 and its ligands in tolerance and immunity. Keir ME, Butte MJ, Freeman GJ, Sharpe AH, Annu Rev Immunol 2008 26 677 704 10.1146/annurev.immunol. 26.021607.090331 18173375 (Pubitemid 351600389)
16. PD-1 and its ligands in T-cell immunity. Keir ME, Francisco LM, Sharpe AH, Curr Opin Immunol 2007 19 309 314 10.1016/j.coi.2007.04.012 17433872 (Pubitemid 46687017)
17. PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients. Kozako T, Yoshimitsu M, Fujiwara H, Masamoto I, Horai S, White Y, Akimoto M, Suzuki S, Matsushita K, Uozumi K, Tei C, Arima N, Leukemia 2009 23 375 382 10.1038/leu.2008.272 18830259
18. B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. Chen LG, Zhang Z, Chen WW, Zhang ZD, Li YG, Shi M, Zhang JY, Chen LP, Wang SD, Wang FS, J Immunol 2007 178 6634 6641 17475895 (Pubitemid 46717448)
19. Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. Rodríguez-García M, Porichis F, de Jong OG, Levi K, Diefenbach TJ, Lifson JD, Freeman GJ, Walker BD, Kaufmann DE, Kavanagh DG, J Leukoc Biol 2011 89 507 515 10.1189/jlb.0610327 21097698
20. Expression profiling of genes associated with regulatory functions of T-cell subsets in Mareks disease virus-infected chickens. Parvizi P, Andrzejewski K, Read LR, Behboudi S, Sharif S, Avian Pathol 2010 39 367 373 10.1080/03079457.2010.508776 20954013
21. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ, Nat Immunol 2001 2 261 268 10.1038/85330 11224527 (Pubitemid 33706004)
22. Effects of reticuloendotheliosis virus and Mareks disease virus infection and co-infection on IFN-gamma production in SPF chickens. Zheng YS, Cui ZZ, Zhao P, Li HM, Liu CY, Tian ZJ, Zhao HK, J Vet Med Sci 2007 69 213 216 10.1292/jvms.69.213 17339769 (Pubitemid 46364398)
23. Human Immunodeficiency Virus Type 1 Nef Induces Programmed Death 1 Expression through a p38 Mitogen-Activated Protein Kinase-Dependent Mechanism. Muthumani K, Choo AY, Shedlock DJ, Laddy DJ, Sundaram SG, Hirao L, Wu L, Thieu KP, Chung CW, Lankaraman KM, Tebas P, Silvestri G, Weiner DB, J Virol 2008 82 11536 11544 10.1128/JVI.00485-08 18799583
24. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling. Yao ZQ, King E, Prayther D, Yin D, Moorman J, Viral Immunol 2007 20 276 287 10.1089/vim.2006.0096 17603844 (Pubitemid 47076209)
25. Deletion of the Meq gene significantly decreases immunosuppression in chickens caused by pathogenic Mareks disease virus. Li Y, Sun A, Su S, Zhao P, Cui Z, Zhu H, Virol J 2011 8 2 10.1186/1743-422X-8-2 21205328
26. Restoring function in exhausted CD8 T cells during chronic viral infection. Barber DL, Wherry EJ, Masopust D, Zhu BG, Allison JP, Sharpe AH, Freeman GJ, Ahmed R, Nature 2006 439 682 687 10.1038/nature04444 16382236 (Pubitemid 43237609)
27. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, Missale G, Ferrari C, J Virol 2006 80 11398 11403 10.1128/JVI.01177-06 16956940 (Pubitemid 44706581)
28. Apoptosis in peripheral CD4+T cells and thymocytes by Mareks disease virus-infection. Morimura T, Ohashi K, Kon Y, Hattori M, Sugimoto C, Onuma M, Leukemia 1997 3 206 208
29. PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention. Kaufmann DE, Walker BD, J Immunol 2009 182 5891 5897 10.4049/jimmunol.0803771 19414738
30. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, Greenfield EA, Freeman GJ, J Immunol 2003 170 1257 1266 12538684 (Pubitemid 36139491)
31. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O, Exp Hematol 2003 31 890 896 10.1016/S0301- 472X(03)00110-3 14550804 (Pubitemid 37211373)
32. RNA fingerprints provide direct evidence for the inhibitory role of TGF beta and PD-1 on CD4+ T cells in Hodgkin lymphoma. Chemnitz JM, Eggle D, Driesen J, Classen S, Riley JL, Debey-Pascher S, Beyer M, Popov A, Zander T, Schultze JL, Blood 2007 110 3226 3233 10.1182/blood-2006-12-064360 17644739 (Pubitemid 350106315)
33. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ, Am J Surg Pathol 2006 30 802 810 10.1097/01.pas.0000209855.28282. ce 16819321 (Pubitemid 44264969)
34. Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma. Shimauchi T, Kabashima K, Nakashima D, Sugita K, Yamada Y, Hino R, Tokura Y, Int J Cancer 2007 121 2585 2590 10.1002/ijc.23042 17721918 (Pubitemid 350136399)
35. Mareks disease virus: from miasma to model. Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S, Nat Rev Microbiol 2006 4 283 294 10.1038/nrmicro1382 16541136
36. Two cell lines from lymphomas of Mareks disease. Akiyama Y, Kato S, Biken J 1974 17 105 116 4616680
37. T lymphoblastoid cell lines from Mareks disease lymphomas. Powell PC, Payne LN, Frazier JA, Rennnie M, Nature 1974 251 79 80 10.1038/251079a0 4547318
38. The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Himly M, Foster DN, Bottoli I, Iacovoni JS, Vogt PK, Virology 1998 248 295 304 10.1006/viro.1998.9290 9721238 (Pubitemid 28417716)
39. Characterisation of two highly oncogenic strains of Mareks disease virus. Schat KA, Calnek BW, Fabricant J, Avian Pathol 1982 11 593 605 10.1080/03079458208436134 18770225
40. Differential effect of maternal antibodies on efficacy of cellular and cell-free Mareks disease vaccines. Witter RL, Burmester BR, Avian Pathol 1979 8 145 156 10.1080/03079457908418337 18770437
41. Development of a real-time PCR assay using SYBR Green chemistry for monitoring Mareks disease virus genome load in feather tips. Abdul-Careem MF, Hunter BD, Nagy E, Read LR, Sanei B, Spencer JL, Sharif S, J Virol Methods 2006 133 34 40 10.1016/j.jviromet.2005.10.018 16300836
42. Difference in the meq gene between oncogenic and attenuated strains of Mareks disease virus serotype 1. Lee SI, Takagi M, Ohashi K, Sugimoto C, Onuma M, J Vet Med Sci 2000 62 287 292 10.1292/jvms.62.287 10770601
43. Overexpression of interferon-activated gene 202 (Ifi202) correlates with the progression of autoimmune glomerulonephritis associated with the MRL chromosome 1. Ichii O, Kamikawa A, Otsuka S, Hashimoto Y, Sasaki N, Endoh D, Kon Y, Lupus 2010 19 897 905 10.1177/0961203310362534 20167632